Skip to Content

M 171 (Nadolol 40 mg)

Pill imprint M 171 has been identified as Nadolol 40 mg.

Nadolol is used in the treatment of migraine prevention; anxiety; esophageal variceal hemorrhage prophylaxis; benign essential tremor; high blood pressure (and more), and belongs to the drug class non-cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Nadolol 40 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Nadolol 40 mg M 171
Nadolol 40 mg M 171
Nadolol 40 mg M 171  Front
Nadolol 40 mg M 171  Back
Nadolol 40 mg M 171
M 171
40 mg
9.00 mm
Prescription only
Drug Class:
Non-cardioselective beta blockers
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
lactose anhydrous
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
D&C Yellow No. 10
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0813 UDL Laboratories Inc
54868-3257 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.